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Ghrelin is known to act on the area postrema (AP), a sensory circumventricular organ located in the
medulla oblongata that regulates a variety of important physiological functions. However, the
neuronal targets of ghrelin in the AP and their potential role are currently unknown. In this study,
we used wild-type and genetically modified mice to gain insights into the neurons of the AP
expressing the ghrelin receptor [growth hormone secretagogue receptor (GHSR)] and their role.We
show that circulating ghrelin mainly accesses the AP but not to the adjacent nucleus of the solitary
tract. Also, we show that both peripheral administration of ghrelin and fasting induce an increase of
c-Fos, a marker of neuronal activation, in GHSR-expressing neurons of the AP, and that GHSR
expression is necessary for the fasting-induced activation of AP neurons. Additionally, we show that
ghrelin-sensitive neurons of the AP are mainly g-aminobutyric acid (GABA)ergic, and that an intact
AP is required for ghrelin-induced gastric emptying. Overall, we show that the capacity of circulating
ghrelin to acutely induce gastric emptying in mice requires the integrity of the AP, which contains a
population ofGABAneurons that are a target of plasma ghrelin. (Endocrinology 158: 1436–1449, 2017)
Ghrelin is a 28–amino acid octanoylated peptidehormone predominantly secreted from endocrine
cells of the gastric mucosa (1). The actions of ghrelin are
mediated by the growth hormone secretagogue receptor
(GHSR), a G protein–coupled receptor highly expressed
in the brain (2). The effects of ghrelin in the central nervous
system are diverse and include modulation of the growth
hormone secretion, food intake, blood glucose homeostasis,
stress responses, and gastrointestinal tract motility, among
others (3). Some of these actions of ghrelin, including ghrelin-
induced food intake and gastric emptying, occur within
minutes after its systemic administration in mice (4). Because
ghrelin transport to the brain across the brain–blood barrier is
very low (5), the rapid central effects of circulating ghrelin
likely involve brain areas with fenestrated capillaries such as
the circumventricular organs. In this regard, it has been shown
that plasma ghrelin can passively and rapidly diffuse through
the fenestrated capillaries of the median eminence, which is
located in close apposition to the hypothalamic arcuate nu-
cleus, where ghrelin activates specific neurons that mediate its
orexigenic actions (6, 7). Other studies suggest that the area
postrema (AP), a key sensory circumventricular organ, is also a
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central target for the effects of circulating ghrelin (6, 8);
however, the neuronal targets of ghrelin in the AP and its
potential role are unclear.
The AP is located in the medulla oblongata within the
caudal brainstem and forms a part of the dorsal vagal com-
plex (DVC), which also consists of the nucleus of the sol-
itary tract (NTS) and the dorsal motor nucleus of the vagus
(DMV). The DVC serves as a major reflex center of the
autonomic nervous system in which the NTS contains the
visceral sensory neurons that receive and integrate in-
formation fromvisceral structures, and theDMVcontains the
efferent cholinergic motor neurons that receive most of their
input from the NTS and innervate a variety of visceral
structures, particularly the gut wall (9). The AP contains a set
of sensory neurons that monitor the levels of circulating
factors and then transfer this information toother brain areas,
including the NTS, to regulate a variety of physiological re-
flexes (10). A subset of AP neurons express GHSR (2, 11),
and peripherally administered ghrelin increases themarker of
cellular activation c-Fos in some AP cells (6, 8, 12). Elec-
trophysiological recordings of isolated AP neurons have also
shown that ghrelin affects the membrane potential of a
fraction of them (13). Notably, we have recently shown that
the AP, together with the arcuate nucleus/median eminence
region, is one the few brain areas directly accessible to cir-
culating ghrelin (6). Thus, it seems that the AP is a key site
mediating the effects of circulating ghrelin on the DVC. The
NTS also contains a high density of GHSR-expressing cells
(2), but previous observations that AP ablation impairs
ghrelin-induced increase of c-Fos in theNTS have favored the
notion that the AP is the primary target of ghrelin within the
DVC (8). To our knowledge, however, no study has dissected
the specific neuronal targets of circulating ghrelin within the
AP and their role. Interestingly, it has been suggested that
theDVCisakey regulatorofghrelin-inducedgastric emptying
(14), and gastric prokinetic actions of ghrelin are currently
under investigation as a potential treatment of gastroparesis
and delayed gastric emptying (15). Thus, it would be very
valuable togainabetter understandingof theneuronal circuits
through which ghrelin regulates the DVC function.
The goal of the present studywas to gain insight into the
role of the AP as a target of ghrelin. Overall, we confirmed
that the AP is the only DVC site accessible to circulating
ghrelin, and identified the phenotype of those AP neurons
responsive to ghrelin. Also, we showed that an intact AP
is required for ghrelin-induced gastric emptying.
Materials and Methods
Mice
This study was performed using 3- to 5-month-old male mice
generated in the animal facility of the InstitutoMultidisciplinario de
Biologı´a Celular. Experimental animals included the following. (1)
Wild-type mice, on a pure C57BL/6 background. (2) GHSR-
enhanced green fluorescent protein (eGFP) mice, in which the
eGFP is under the control of the GHSR promoter (16). These mice
[originally from theMouse Mutant Regional Resource Center
Repository, Tg(Ghsr-EGFP)KZ65Gsat; stock no. 030942]
were derived from crosses between hemizygous animals back-
crossed .10 generations onto a C57BL/6 genetic background.
(3) Gad2-tdTomato mice, in which tdTomato red fluorescent
protein is expressed in g-aminobutyric acid (GABA) Gad2-
expressing neurons. These mice were generated by crossing
Gad2-CreERmice andAi14mice. Gad2-CreERmice [originally
from The Jackson Laboratory,Gad2tm1(cre/ERT2)Zjh/J; stock no.
010702] express a tamoxifen-inducible Cre recombinase under
the endogenous promoter elements of the Gad2 gene (17). Ai14
mice [originally from the Allen Institute, 129S6-Gt(ROSA)
26Sortm14(CAG-tdTomato)Hze/J; stock no. 007908] harbor a tar-
geted mutation of the Gt(ROSA)26Sor locus with a loxP-flanked
STOP cassette preventing the transcription of the tdTomato (18),
which is expressed only followingCre-mediated recombination. The
Gad2-CreERT2 and Ai14 mice were bred with pure wild-type
C57BL/6 mice for at least eight generations after their arrival to
the InstitutoMultidisciplinario de Biologı´a Celular. Two-month-old
Gad2-tdTomato mice received a daily dose of tamoxifen [70 mg/kg
body weight (BW), intraperitoneally] or vehicle (sesame oil) for
4 consecutive days to induce Cre recombination. After 3 weeks,
the pattern of red fluorescent cells displayed the distribution
of Gad2 expression, as previously shown (17). (4) GHSR-eGFP/
Gad2-tdTomato mice, in which tdTomato is expressed in GABA
Gad2-expressing cells and eGFP is expressed in GHSR-expressing
cells. These mice were generated by crossing Gad2-tdTomato
mice and GHSR-eGFP or GHSR-eGFP/Ai14 mice. GHSR-eGFP/
Gad2-tdTomato mice were injected with tamoxifen as described
above. (5) GHSR-null mice, which fail to express the GHSR (19),
were derived from crosses between heterozygous animals back-
crossed.10 generations onto a C57BL/6 genetic background. All
mice were housed in a 12-hour light/dark cycle in standard en-
vironmentally controlled conditions with regular chow and water
available ad libitum, except when indicated otherwise.
Ethics statement and animal care
All experiments received approval from the Institutional Animal
Care and Use Committee of the Instituto Multidisciplinario de
Biologı´a Celular (ID no. 10-0112). This study was carried out in
strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the US National Research
Council, and all efforts were made to minimize suffering. To reveal
an effect of endogenous rises in circulating ghrelin at the AP, we
needed to use 48 hours of food deprivation becausemice fasted such
length of time showed a significant increase of the number of cells
positive for c-Fos in the AP, as compared with the number found in
ad libitum fed mice, that was not detected in mice fasted 24 hours
(unpublished observations). Importantly, 48-hour fasting is a ma-
nipulation fully tolerated by wild-type mice that display a normal
overall health status and locomotor activity (20). All mice were
individually housed 3 days before starting the experiments, which
were performed in the morning, between 9:00 AM and 11:30 AM.
Analysis of DVC sites responsive to
circulating ghrelin
In this study, we peripherally injected a fluorescent ghrelin
tracer into mice and then mapped the distribution of the tracer
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as well as the induction of phosphorylated extracellular signal-
regulated kinase (p-ERK) in the DVC. Specifically, ad libitum
fed wild-type mice were subcutaneously injected with either
phosphate-buffered saline (PBS) alone or containing 0.3 nmol/g
BW of fluorescein-ghrelin (n = 4 and 5, respectively). The
fluorescent ghrelin (F-ghrelin) is an analog of the hormone
ghrelin with a fluorescein moiety attached at its C terminus.
F-ghrelin behaves similarly to ghrelin and can be used to study
both binding and uptake of this hormone (21). Importantly, we
have validated the specificity of this tracer by showing that
F-ghrelin: (1) is bioactive in vivo; (2) labels the mouse brain
with a pattern similar to that seen for GHSR messenger RNA
(mRNA) expression; and (3) fails to label brain nuclei of GHSR-
null mice (11). F-ghrelin was provided byDr. L.G. Luyt from the
University of Western Ontario (London, ON, Canada). Thirty
minutes after treatment, micewere anesthetized and perfused, as
described previously (22). Brains were dissected and processed
to generate three equivalent series of 40-mm-thick coronal brain
sections, which were used for immunohistochemistry. Two
series of sections of each animal were pretreated with 0.5%
H2O2 and treated with blocking solution (3% normal donkey
serum and 0.25% Triton-X in PBS). A series of sections of each
animal were incubated with either a goat anti-fluorescein an-
tibody (Table 1) for 48 hours at 4°C, or a goat anti–p-ERK
antibody (Table 1) overnight at room temperature. Next, all
sections were treated with biotinylated donkey anti-goat anti-
body (Vector Laboratories, catalog no. BA-5000; 1:1000), and
then with a Vectastain Elite ABC kit (Vector Laboratories, cat-
alog no. PK-6200), according to the manufacturer’s protocols.
Finally, a visible signal was developed with diaminobenzidine
(DAB)/nickel solution, giving a black/purple precipitate. Anti-
fluorescein immunostaining is specific, as immunostained brain
sections of vehicle-treated mice display similar background sig-
nal as detected in negative control samples, in which either the
primary or secondary antibody was omitted in the staining
procedure (11).
Analysis of the responsiveness of eGFP cells of the
DVC to exogenously administered ghrelin
In this study, wemapped the induction of c-Fos in the AP and
the NTS of GHSR-eGFP mice that had been peripherally or
centrally injected with ghrelin. A set of GHSR-eGFP mice (n = 6
per group) was subcutaneously injected with PBS alone or
containing 0.3 nmol/g BW of ghrelin (Global Peptide, catalog
no. PI-G-03). Another set of GHSR-eGFP mice was stereo-
taxically implanted with an intracerebroventricular (ICV) guide
cannula in the lateral ventricle (placement coordinates: ante-
roposterior, 20.34 mm, lateral, +1 mm; ventral, 22.3 mm).
Seven days after surgery, mice (n = 6 per group) were ICV
injected with 2mL of vehicle (artificial cerebrospinal fluid) alone
or containing ghrelin (0.3 nmol per mouse). Mice were anes-
thetized and perfused 2 hours after treatment. Brains were
dissected and coronally cut, as described above. In these ex-
perimental conditions, centrally injected ghrelin reaches most of
its brain targets, including the DMV and the NTS (2, 11). The
location of the cannula injectors into the lateral ventricle was
verified at the end of the experiment by the histological analysis
of the brain sections. For immunohistochemistry, sections were
pretreated as indicated above and then incubated with a rabbit
anti–c-Fos antibody (Table 1) for 48 hours at 4°C. Then, sec-
tions were incubated with biotinylated anti-rabbit antibody
(Vector Laboratories, catalog no. BA-1000; 1:3,000). Visible
signal was developed with the Vectastain Elite ABC kit and a
DAB/nickel solution, as also described above. Then, c-Fos
immunostained sections were incubated with a rabbit anti-
eGFP antibody (Table 1) for 48 hours, and sequentially in-
cubated with a secondary antibody and the Vectastain Elite
ABC kit, as detailed above. Finally, visible signal was developed
with DAB solution, which generates a brown precipitate.
Analysis of the responsiveness of eGFP cells of the
DVC to endogenous increments of plasma ghrelin
In this study, wemapped the induction of c-Fos in the AP and
the NTS of GHSR-eGFP mice that had been fasted. In partic-
ular, GHSR-eGFPmice were kept ad libitum fed (n = 5) or fasted
(n = 6) by removing their food at 10:00 AM. After 48 hours,
animals were weighed, and mouse brains were obtained and
processed for double immunohistochemistry against c-Fos and
eGFP as described above. Blood samples were collected from
mouse tails immediately before perfusion, and plasma glu-
cose and ghrelin levels were determined using an enzymatic
colorimetric assay (Weiner Laboratory) or a ghrelin enzyme
immunoassay kit (Cayman Chemical Company), according to
the manufacturer’s instructions. Visceral fat pads were dissected
from perfused mice and weighed. In an independent study, we
also mapped the induction of c-Fos in the AP of 48-hour fasted
Table 1. Antibodies Used
Peptide/
Protein
Target
Name of
Antibody Source
Species Raised in;
Monoclonal or
Polyclonal Dilution Used RRID
Fluorescein/
Oregon
Green
Antifluorescein/
Oregon Green®
Molecular Probes, catalog
no. A-11096
Goat; polyclonal 1:1500 AB_221558
p-ERK1/2 p-ERK1/2 antibody
(Thr202/Tyr204)
Santa Cruz Biotechnology,
catalog no. SC-16982
Goat, polyclonal 1:500 AB_2139990
c-Fos c-Fos antibody (H-
125)
Santa Cruz Biotechnology,
catalog no. SC-7202
Rabbit; polyclonal 1:4000 (chromogenic IHC);
1:1000 (fluorescent IHC)
AB_2106765
GFP GFP tag polyclonal
antibody
Molecular Probes, catalog
no. A-6455
Rabbit; polyclonal 1:20,000 AB_221570
TH TH antibody (H-
196)
Santa Cruz Biotechnology,
catalog no. SC-14007
Rabbit; polyclonal 1:20,000 (chromogenic IHC);
1:5000 (fluorescent IHC)
AB_671397
Abbreviations: IHC, immunohistochemistry; RRID, Research Resource Identifier; TH, tyrosine hydroxylase.
1438 Cabral et al Action of Ghrelin in the Area Postrema Endocrinology, May 2017, 158(5):1436–1449
D
ow
nloaded from
 https://academ
ic.oup.com
/endo/article-abstract/158/5/1436/2997444 by guest on 04 Septem
ber 2019
wild-typemice that received, ornot, fluid replacement (n=5pergroup)
with two daily injections of sterile warm saline (0.01 mL/g BW).
The brains of these mice were obtained and processed for im-
munohistochemistry against c-Fos, as described above.
Analysis of the requirement of ghrelin signaling for
the fasting-induced activation of the AP cells
In this study, we quantified the induction of c-Fos in the AP
of fed and fasted GHSR-null mice. In particular, wild-type and
GHSR-null mice were kept ad libitum fed or fasted by removing
their food at 10:00 AM. In this experiment, we used a total of 23
mice that were divided as follows: wild-type fed (n = 4), GHSR-
null fed (n = 6), wild-type fasted (n = 6), and GHSR-null fasted
(n = 7). After 48 hours, mouse brains were obtained and processed
for immunohistochemistry against c-Fos, as described above.
Characterization of the phenotype of eGFP cells of
the AP
In this study, we tested whether eGFP neurons of the AP of
the GHSR-eGFPmice were catecholaminergic or GABAergic. In
both cases, we tested whether each neuronal type either ex-
presses eGFP or increases c-Fos in response to ghrelin. In one
case, a red fluorescent immunostaining against tyrosine hy-
droxylase (TH), the gold standard marker in the identification
of catecholaminergic neurons, was performed. Thus, brain
sections of GHSR-eGFP mice (n = 4) were treated with blocking
solution and incubatedwith a rabbit anti-THantibody (Table 1)
for 48 hours at 4°C. Then, sections were incubated with an
Alexa Fluor 594 anti-rabbit antibody (Molecular Probes, cat-
alog no. A21207; 1:1000) for 2 hours. Additionally, we per-
formed a double chromogenic immunostaining against c-Fos
and TH in coronal brain sections of wild-type mice that had
been subcutaneously treatedwith either vehicle (n = 5) or ghrelin
(0.3 nmol/g BW, n = 3) and perfused 2 hours afterward. The
immunostaining against c-Fos and THwas performed using the
double immunohistochemistry strategy described above, but
using a rabbit anti-TH antibody (Table 1) instead of the anti-
eGFP antibody. To test whether eGFP-expressing cells of the AP
were GABAergic, we mapped the colocalization of red and
green cells in the AP of brain sections of the GHSR-eGFP/Gad2-
tdTomato mice (n = 3). Additionally, we performed an im-
munostaining against c-Fos in brain sections of Gad2-tdTomato
mice that had been subcutaneously treated with either vehicle
(n = 3) or ghrelin (0.3 nmol/g BW, n = 4) and perfused 2 hours
afterward. In this case, brain sections were treatedwith blocking
solution and incubated with anti–c-Fos antibody (Table 1) for
48 hours at 4°C. Then, sections were incubated with an Alexa
Fluor 488 anti-rabbit antibody (Molecular Probes, catalog no.
A-11008; 1:1000) for 2 hours.
Neuroanatomical quantitative analysis
Bright-field images were acquired with a DS-Ri1 Nikon
digital camera. Fluorescent images were acquired with a laser-
scanning Olympus FV1000 confocal microscope with emission
filters of 490 to 540 nm for eGFP detection (laser 473 nm) and
575 to 675 nm for Alexa 594 or tdTomato detection (laser
559 nm). All images were taken in comparable areas and under
the same optical and light conditions. Anatomical limits of the
AP and NTS were identified using a mouse brain atlas (23),
together with coronal brain sections of wild-type mice stained
with thionin (0.025%, Sigma-Aldrich, catalog no. T7029).
Quantitative analyses were performed on every third section
between bregma27.20 and27.92 mm for the AP and between
bregma 26.24 and 27.76 mm for the NTS; thus, at least five
sections containing the AP and 10 sections containing the NTS
were analyzed per mouse. For quantification of the fluorescein-
immunoreactive (IR) and p-ERK-IR chromogenic signals, 16-bit
color photomicrographs were converted into 32-bit grayscale
images and their optical density (OD) was calculated by taking
the negative decimal logarithm of the original gray values di-
vided by the corresponding values from a white flat-field image
using the software Fiji (National Institutes of Health). Themean
OD was determined in the AP, the NTS, and the medullary
reticular nucleus, which was used as a control region because it
does not express GHSR and, as a consequence, no fluorescein-IR
or p-ERK signals were expected or detected. The fluorescein-
IR and the p-ERK-IR signals are expressed as relative OD per
section, as compared with the mean OD value in the medullary
reticular nucleus, and then normalized to the levels found in the
vehicle-treated group. For c-Fos immunostaining, the total
number of cells containing a nuclear purple-black precipitates
signal (c-Fos+ cells) was estimated in the AP and the NTS. To
quantify c-Fos induction in specific neuronal types, all eGFP-IR
(eGFP+) cells, TH-IR (TH+) cells, or tdTomato+ cells that were
c-Fos+ and c-Fos2 were counted in each case. To estimate the
phenotype of the AP eGFP-expressing cells, the total number of
green fluorescence– and/or red fluorescence–labeled cells was
quantified in AP of either brain slices of GHSR-eGFP mice
immunostained against TH or brain slices of GHSR-eGFP/
Gad2-tdTomato mice. All data were corrected for double
counting, according to the method of Abercrombie (24), where
the ratio of the actual number of neurons or cell nuclei to the
observed number is represented by T/(T + h), where T is sec-
tion thickness and h is the mean diameter of the neuron or cell
nuclei along the z-axis. Themean diameter of the neurons or cell
nuclei was determined using Fiji. Blind quantitative analysis was
performed independently by at least two observers in one series
per animal.
Analysis of the requirement of the AP for the
ghrelin-induced gastric emptying
To ablate the AP, anesthetized wild-typemice were subjected
to a surgical incision between the occipital crest andmidcervical
region. The foramen magnum was slightly enlarged, exposing
the AP. The AP was aspirated with a 25-gauge needle and the
skin was closed in a set of mice (AP-ablated), whereas the skin
was sutured without any manipulation in another set of mice
(AP-intact). Mice were daily treated with flunixin meglumine
(Flumeg 5%) for 4 consecutive days to reduce inflammation and
maintained with ad libitum access to food and water. After
1week, ghrelin-induced food intakewas assessed in a cross-over
designed manner. In particular, mice were subcutaneously
treated with PBS alone or containing ghrelin (0.3 nmol/g BW)
in a randomized alternating scheme on consecutive days. Food
intake was calculated by subtracting the remaining food weight
2 hours after treatment from the initial food weight. After
4 days, the gastric emptying was measured using the gold
standard phenol red method (25). Briefly, ad libitum fed mice
were administered with 0.1 mL of test solution (0.5 mg/mL
phenol red and 5% glucose in water) by oral gavage using a
bulb-tipped gastric feeding needle. After 1 minute, mice were
subcutaneously injected with either vehicle alone or containing
ghrelin (0.3 nmol/g BW). After 20 minutes, anesthetized mice
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were euthanized by decapitation and their stomachs were ex-
posed by laparotomy, quickly ligated at both the pylorus and
the esophagus–gastric junction, and removed. Stomachs and
their contents were homogenized in 0.1NNaOH; proteins were
precipitated using 20% trichloroacetic acid and further cen-
trifugation. Finally, supernatants were mixed with 4MNaOH,
and the 540 nm absorbance was measured. The gastric emp-
tying was expressed as a percentage and calculated according to
the following equation: [1 2 (absorbance in test stomach/
average of initial absorbance)] 3 100. The initial absorbance
was obtained with an independent group of mice (n = 3), which
was euthanized 1 minute after the administration of the test
solution, and their stomachs were processed as described above.
After the assessment of gastric emptying, brains were dissected,
fixed overnight in 4% formaldehyde, and coronally cut. Then,
the sections were mounted, stained with thionin, and used to
estimate the extent of the AP lesion. Mice with partial lesions of
the AP or significant lesions of the NTS were excluded from the
analysis. After the confirmation of the complete AP ablation, a
total of 41 mice were included in the analysis and grouped as
follows: vehicle-treated AP-intact (n = 18), ghrelin-treated
AP-intact (n = 12), vehicle-treated AP-ablated (n = 5), and
ghrelin-treated AP-ablated (n = 6).
Statistical analysis
Data are expressed as themean6 standard error of themean
(SEM). Equality of variance was analyzed using Bartlett’s test.
t test was performed to compare data from vehicle- vs ghrelin-
or F-ghrelin–treated mice. Two-way analysis of variance
(ANOVA) followed by the Bonferroni test was used to compare
data from experiments of fasting and of gastric emptying.
Significant differences were considered when P , 0.05.
Results
Peripherally administered ghrelin impacts theAPbut
not the NTS
First, we analyzed if circulating ghrelin accesses the AP
and the NTS, which are the components of the DVCwith
highest density of GHSR-expressing cells (2, 16). For this
purpose, we subcutaneously injected mice with F-ghrelin
and mapped the presence of this tracer in the AP and the
NTS [Fig. 1(a)]. Because fluorescence lifetime of F-ghrelin
is short, we used an antifluorescein antibody followed
by chromogenic immunostaining to stabilize the signal
and increase the sensitivity of the assay (11). As com-
pared with vehicle-treated mice, F-ghrelin–treated mice
showed a significant increase of fluorescein-IR signal
intensity in the AP, whereas no significant differences
were detected in the NTS [Fig. 1(b) and 1(c)]. Addi-
tionally, we studied the activation of the ERK signaling,
as a direct marker of ghrelin action (26), to further
characterize the primary targets of circulating hormone
within the DVC [Fig. 1(d)]. Quantitative analysis in-
dicated that F-ghrelin–treated mice showed a significant
increase of p-ERK-IR signal intensity in theAP,whereas no
significant differences were detected in the NTS [Fig. 1(e)
and 1(f)]. Thus, peripherally administered F-ghrelin ac-
cesses and directly activates the AP region of the DVC.
Peripherally administered ghrelin activates
GHSR-expressing cells of the AP and fails to activate
GHSR-expressing neurons of the NTS
To better characterize the response to ghrelin of the
different DVC components, we used GHSR-eGFP mice,
in which eGFP expression reports on the location of
GHSR-expressing cells. We have recently shown that
eGFP+ cells are detected in all three nuclei of the DVC of
the GHSR-eGFPmice and that they show a high degree of
colocalization with GHSR mRNA, indicating that these
mice are a useful tool for studying GHSR function in the
brainstem (16). We have also shown that visualization of
eGFP+ neurons within this mouse model by either direct
detection of eGFP fluorescence or chromogenic immu-
nostaining displays a very similar neuroanatomical pat-
tern of signal (16). The neuroanatomical analysis of eGFP
cells reported in the present study was performed using
chromogenic immunostaining because this strategy is
more sensitive due to the amplification steps of the re-
action. Within the AP, the number of eGFP+ neurons was
quantified as 837 6 74. These cells were relatively ho-
mogeneous, mostly small sized (average diameter, 9.2 6
0.2 mm) and dark stained as compared with eGFP neu-
ronswithin the other DVC regions. TheAP eGFP neurons
were densely packed, and most of them displayed a single
ventrolaterally projecting fiber [Fig. 2(a)].
Peripheral administration of ghrelin to wild-type mice
increases the number of cells positive for c-Fos in both the
AP and the NTS (6). To test the ability of GHSR-
expressing neurons of the DVC to respond to circula-
ting ghrelin, we peripherally administered ghrelin to
GHSR-eGFPmice andmapped c-Fos in eGFP+ and eGFP2
neurons [Fig. 2(b)]. Quantitative analysis was perfor-
med in both the AP and the NTS nuclei. As compared
with vehicle-treated animals, ghrelin-treated GHSR-
eGFP mice showed a significant increase in the number
of c-Fos+/eGFP+ cells in the AP [Fig. 2(c)], representing
18.7% 6 5.9% vs 45.6% 6 8.2% of total AP eGFP+
cells, respectively, and failed to show a significant in-
crease in the number of c-Fos+/eGFP2 cells (23 6 5 vs
116 4 cells per AP, for ghrelin- and vehicle-treated mice,
respectively, P = 0.082). In the NTS, ghrelin-treated
GHSR-eGFP mice failed to show an increase in the
number of c-Fos+/eGFP+ cells vs vehicle-treated animals
[Fig. 2(d)], representing 14.4%6 3.0% vs 8.2%6 4.0%
of total NTS eGFP+ cells, respectively, but showed a
significant increase in the number of c-Fos+/eGFP2 cells
[Fig. 2(e)]. To test whether eGFP+ neurons of the NTS
are able to increase c-Fos in response to ghrelin, we
mapped c-Fos induction in the DVC of GHSR-eGFPmice
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ICV injected with ghrelin [Fig. 2(f)]. As
compared with ICV vehicle-treated ani-
mals, GHSR-eGFP mice ICV treated
with ghrelin showed a significant in-
crease in the number of c-Fos+/eGFP+
cells in the AP [Fig. 2(g)], representing
16.8% 6 5.0% vs 71.7% 6 6.6% of
total AP eGFP+ cells, respectively. In
the NTS, GHSR-eGFP mice ICV
treated with ghrelin showed a significant
increase of the number of c-Fos+/eGFP+
cells [Fig. 2(h)], representing 40.9% 6
7.1% vs 8.6% 6 3.7% of total NTS
eGFP+ cells, respectively, as well as
of the number of c-Fos+/eGFP2 cells
[Fig. 2(i)]. None of these experi-
mental manipulations affected the
total number of eGFP+ cells in the AP
or the NTS of GHSR-eGFP mice (not
shown). Collectively, these data in-
dicate that circulating ghrelin acts
on GHSR-expressing neurons of the
AP whereas it fails to activate GHSR-
expressing neurons of the NTS, which
can be activated by centrally adminis-
tered ghrelin.
GHSR-expressing cells of the AP
respond to 48-hour fasting
To test whether GHSR-expressing
neurons of the AP are sensitive to en-
dogenous rises in circulating ghrelin,
we quantified the induction of c-Fos in
eGFP-expressing neurons of the AP
and the NTS of fasted GHSR-eGFP
mice. Fasted mice displayed a good
overall health status without signs
of dehydration (i.e., displayed normal
skin turgor) during the fasting period.
As compared with ad libitum fed ani-
mals, fasted GHSR-eGFP mice lost
;19% of BW and;65% of their body
fat, and they displayed hypoglycemia
as well as an increase of plasma ghrelin
levels (Table 2). As compared with fed
animals, fasted GHSR-eGFP mice dis-
played an increase of the number of
c-Fos+/eGFP+ cells in the AP [Fig. 3(a)
and 3(b)], representing 12.1%6 2.8%
vs 36.1% 6 5.4% of total AP eGFP+
cells, respectively, as well as an increase
in the number of c-Fos+/eGFP2 cells
(20 6 7 vs 585 6 78 cells per AP
Figure 1. Peripherally administered F-ghrelin exclusively impacts the AP component of the
DVC. (a and d) Representative images of DVC of vehicle- and F-ghrelin–treated mice (n = 4
and 5, respectively) subjected to chromogenic immunostaining against fluorescein and p-ERK,
respectively. Insets in each image show high magnification of the areas marked in low-
magnification images. Scale bars, 100 and 10 mm for the low- and high-magnification
images, respectively. Bar graphs of quantitative analysis of fluorescein-IR (b and c) and p-ERK-
IR ODs (e and f) are shown. Data represent the mean 6 SEM. *P , 0.05 vs vehicle group.
SC, subcutaneous.
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for fed vs fasted mice, respectively,
P , 0.05). In the NTS, fasted GHSR-
eGFP mice failed to change the number
of c-Fos+/eGFP+ cells as compared with
fed GHSR-eGFP mice [Fig. 3(c)], rep-
resenting 3.4% 6 1.3% vs 5.3% 6
1.8% of total NTS eGFP+ cells, re-
spectively, but they displayed a sig-
nificant increase of the number of
c-Fos+/eGFP2 cells [Fig. 3(d)]. Because
food intake deprivationmay affect body
fluid homeostasis, we compared c-Fos
induction in the AP of fasted wild-type
mice that received, or not, fluid therapy
in an independent experiment, in which
we found similar numbers of c-Fos+ cells
in both experimental groups (5246 94
and 464 6 108, respectively).
Fasting-induced activation of AP
neurons requires GHSR expression
To test whether ghrelin signaling is
required for the fasting-induced in-
crease of c-Fos in the AP, we quantified
the number of c-Fos+ cells in the AP of
wild-type and GHSR-null mice that
had been ad libitum fed or 48 hours
fasted [Fig. 3(e)]. Two-way ANOVA
revealed a significant interaction be-
tween feeding status and genotype.
In particular, fasted wild-type mice
showed a significant increase of the
number of c-Fos+ cells in the AP, as
compared with fed wild-type animals.
Fed GHSR-null mice displayed a sim-
ilar number of c-Fos+ cells in the AP to
that seen in fed wild-type mice. The
number of c-Fos+ cells in the AP of
fasted GHSR-null mice was ;6.6-fold
that of fed animals (P = 0.1076), and it
was significantly smaller as compared
with the number found in the fasted
wild-type mice [Fig. 3(f)].
AP GHSR-expressing cells are
GABA neurons
One of the main neuronal types
within the AP is known to synthesize
catecholamines (27). To test whether
GHSR-expressing cells of the AP are
catecholaminergic, we performed a
red fluorescent immunostaining against
TH in brain sections of GHSR-eGFP
Figure 2. Peripherally administered ghrelin exclusively impacts GHSR-expressing cells of the
AP of GHSR-eGFP mice. (a) Distribution pattern of eGFP+ cells within the DVC of GHSR-eGFP
mice. Right photomicrograph shows a higher magnification of the area marked in the low-
magnification photomicrograph (left). Arrow 1 points to the cell body of an eGFP cell located
in the AP and arrowheads point to its axon. Arrow 2 points to the cell body of an eGFP cell
located in the NTS. Scale bars, 100 mm (low magnification), 10 mm (high magnification). (b
and f) Representative low-magnification images of the DVC of vehicle- and ghrelin-treated
GHSR-eGFP mice subjected to double chromogenic immunostaining for c-Fos (circle-like
black) and eGFP (gray) (n = 6 per group). Insets in each image show high magnification
of the areas marked in low-magnification images. Arrows point to dual-labeled cells.
Scale bars, 100 mm (low magnification), 10 mm (high magnification). (c, d, g, and h) Bar
graphs displaying the number of eGFP+ cells positive for c-Fos in the AP and NTS in each
experimental condition. (e and i) Bar graphs displaying the number c-Fos+ cells negative
for eGFP in the NTS in each experimental condition. Data represent the mean 6 SEM.
*P , 0.05, **P , 0.01, ***P , 0.001 vs vehicle group. SC, subcutaneous.
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mice.NoTH+/eGFP+ neuronswere detected in theAP [Fig.
4(a)]. To determine whether ghrelin activates AP cate-
cholaminergic neurons, we performed double immuno-
staining against TH and c-Fos in brain samples of wild-
type mice peripherally treated with ghrelin, and we found
that ghrelin-treatedmice failed to show c-Fos+/TH+ cells in
the AP [Fig. 4(b)].
Another key subset of neurons of the AP produces
GABA (28). To test whether AP GHSR-expressing cells
are GABAergic, we generated GHSR-eGFP/Gad2-
tdTomato transgenic mice that express eGFP in GHSR-
expressing cells and tdTomato in Gad2-expressing
(GABAergic) cells. The distribution pattern of eGFP+
cells and tdTomato+ cells in the GHSR-eGFP/Gad2-
tdTomato reporter mice was similar to that seen in
each independent mouse model (not shown). The quan-
titative analysis of the degree of colocalization in the AP
indicated that double tdTomato+/eGFP+ cells represent
69%6 8% of the total AP eGFP+ cells and 18%6 4% of
the total AP tdTomato+ cells [Fig. 4(c)]. To test whether
ghrelin activatesAPGABAergic neurons,we analyzed c-Fos
induction in the AP of Gad2-tdTomato mice peripher-
ally treated with ghrelin. Ghrelin-treated mice displayed
a significant increase of the percentage of c-Fos+/tdTomato+
cells in the AP, as compared with the percentage found in
vehicle-treated mice [9%6 2% vs 0%6 0%, respectively,
P , 0.05, Fig. 4(d)].
Ghrelin-induced gastric emptying is impaired in
AP-ablated mice
The AP mediates the gastric emptying effects of other
hormones (29), and ghrelin is able to induce gastric
emptying in mice (30). Thus, we tested whether the effect
of ghrelin on the gastric emptying requires an intact AP.
For this purpose, we generated AP-intact and AP-ablated
mice using a surgical strategy [Fig. 5(a)]. First, we tested
the ability of ghrelin to increase food intake. We found
that ghrelin-injected AP-intact mice significantly increase
food intake, as compared with their own food intake in
response to vehicle, and that ghrelin-injected AP-ablated
mice also significantly increase food intake, as compared
with their own food intake in response to vehicle [Fig.
5(b)]. Ghrelin-induced food intake did not significantly
differ between AP-intact and AP-ablated mice, and no
interaction between group and treatment was found by
two-way ANOVA. Then, we tested the ability of ghrelin
to affect gastric emptying [Fig. 5(c)]. Two-way ANOVA
revealed no significant interaction between the effects
of ablation and treatment. However, ghrelin-injected
AP-intact mice showed a significant increase of the per-
centage of gastric emptying, as compared with vehicle-
injectedAP-intactmice (P,0.01),whereas ghrelin-injected
AP-ablated mice failed to increase the percentage of
gastric emptying, as compared with vehicle-injected AP-
ablated mice.
Discussion
The AP is one of the most highly vascularized regions in
the brain (31); because this dense vascular supply is
devoid of a blood–brain barrier, AP cells are permanently
exposed to circulating molecules, including ghrelin (10).
GHSR is highly expressed in the AP, and ghrelin increases
c-Fos levels as well as the electrical activity of some AP
neurons (2, 6, 13). Thus, our finding that peripherally
administered F-ghrelin accesses and increases p-ERK in
theAPwas expected. Our studies usingGHSR-eGFPmice
showed that peripherally administered ghrelin increases
c-Fos levels exclusively in GHSR-expressing cells of the
AP, which, in turn, send projections toward other brain
areas. In contrast, peripherally administered F-ghrelin
failed to access or to increase p-ERK in the NTS,
which also expresses GHSR (2, 6, 13), and peripherally
administered ghrelin increases c-Fos levels in NTS cells
that lack GHSR. Overall, current data suggest that the
AP is the component of the DVC that senses plasma
ghrelin concentrations, whereas the NTS is not directly
targeted by circulating ghrelin, and this presumably oc-
curs due to the presence of the funiculus separans, which
is a layer of cells that functions as a barrier separating the
AP from the underlying brain tissue (10).
The peripheral administration of ghrelin in our
experimental conditions acutely increases the plasma
hormone concentration, peaking a few minutes after
injection and then dropping to basal levels by ;60
minutes later; the transient elevation of circulating ghrelin
represents a ;10-fold increase at 30 minutes after
treatment, as compared with basal levels (6, 26). A 10-
fold elevation of plasma ghrelin levels is comparable
to the increase found in chronically food-restricted
mice (32). To test the responsiveness of AP neurons to
endogenous ghrelin, we tested the induction of c-Fos in
48-hour fasted mice, which display an approximately
twofold increase of plasma ghrelin levels. Using GHSR-
eGFPmice, we found that 48 hours fasting increases c-Fos
in both GHSR-expressing and GHSR-lacking cells of the
Table 2. Parameters of Ad Libitum Fed and Fasted
GHSR-eGFP Mice
Fed Fasted
BW, g 25.4 6 1.0 20.5 6 0.7a
Visceral fat, g 0.55 6 0.06 0.19 6 0.03a
Glucose, mg/mL 138 6 8 87 6 11a
Ghrelin, pg/mL 382 6 43 701 6 121a
aP , 0.05 vs fed mice.
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Figure 3. GHSR-expressing cells of the AP are activated by fasting, and fasting-induced activation of the AP requires GHSR signaling. (a)
Representative low-magnification images of DVC of GHSR-eGFP mice ad libitum fed or 48-hour fasted subjected to double chromogenic
immunostaining for c-Fos (circle-like black) and eGFP (gray) (n = 5 and 6, respectively). Insets in each image show high magnification of the areas
marked in low-magnification images. Arrows point to dual-labeled cells. Scale bars, 100 mm (low magnification), 10 mm (high magnification). (b and
c) Bar graphs displaying the number of eGFP+ cells positive for c-Fos in the AP and NTS in each experimental condition. (d) Bar graphs displaying the
number c-Fos+ cells negative for eGFP in the NTS in each experimental condition. Data represent the mean 6 SEM. *P , 0.05, ***P , 0.001 vs
eGFP mice fed. (e) Representative low-magnification (320) images of AP of wild-type and GHSR-null mice ad libitum fed or 48-hour fasted
subjected to chromogenic immunostaining for c-Fos (circle-like black). Scale bar, 100 mm. (f) Bar graphs of quantitative analysis of the number
of c-Fos-IR cells in the AP in each experimental condition. Data represent the mean 6 SEM. aP , 0.001 vs wild-type fed; bP , 0.001 vs wild-type fasted.
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AP. A fasting-induced increase of c-Fos in AP cells that
lack GHSR was expected because this DVC region also
contains neurons responsive to other metabolic or hor-
monal factors (i.e., glucose, insulin, leptin, CCK), which
are also altered during fasting (10). The observation that
fasting increases c-Fos only in GHSR-lacking cells of the
NTS of 48-hour fasted GHSR-eGFPmice goes along with
the notion that GHSR-expressing cells of the NTS do not
sense plasma ghrelin levels. Fasting is known to decrease
water intake that may, in turn, induce dehydration-
mediated activation of the AP (10, 33); however, the
fasting-induced increase of c-Fos in the AP was not af-
fected by fluid therapy, suggesting that activation of the
AP is not related to alterations of the body fluid balance.
Figure 4. AP GHSR-expressing cells are GABA neurons. (a) Representative confocal photomicrographs of the AP of a GHSR-eGFP mouse
subjected to fluorescent immunostaining against TH; left photomicrograph shows eGFP cells, middle photomicrograph shows TH-IR cells, and the
right photomicrograph shows the merge of the respective left and middle images. (b) Representative low-magnification (320) magnification
images of the AP of vehicle- and ghrelin-treated wild-type mice subjected to double immunostaining for c-Fos (circle-like black) and TH (gray).
(c) Representative confocal photomicrographs of the AP of a GHSR-eGFP/Gad2-tdTomato mouse; left photomicrograph shows eGFP cells, middle
photomicrograph shows tdTomato cells, and right photomicrograph shows the merge of the respective left and middle images. (d) Representative
confocal photomicrographs of the AP of vehicle- and ghrelin-treated Gad2-tdTomato mice subjected to fluorescent immunostaining against c-Fos
(lighter circle-like signal). Inserts in each panel shows in high magnification the areas marked in low-magnification photomicrographs. Arrows
point to dual-labeled cells. Scale bars, 100 mm (low magnification), 10 mm (high magnification).
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In contrast, the fasting-induced increase of c-Fos in the AP
seems to depend on the ghrelin signaling because fasted
GHSR-null mice have an impaired response as compared
with fasted wild-type mice. It is interesting to stress that the
use of 48 hours of food deprivation was based on pilot
studies that showed that only this period of food restriction,
as opposed to 24-hour fasting, induced a significant in-
crease of the number of c-Fos+ cells in the AP, as compared
with the numbers found in ad libitum fed condition (un-
published observations). The reason behind the require-
ment of a more severe fasting condition to reveal a role of
ghrelin signaling in the AP is uncertain, especially because
similar plasma ghrelin levels are found in 24- or 48-hour
fastedmice (20). It can be hypothesized, however, thatmice
fasted for longer periods of time are more sensitive to
ghrelin. Such a notion is supported by studies demon-
strating elevated hypothalamic GHSR mRNA levels in
48-hour fasted mice as compared with ad libitum fed and
24-hour fasted mice (20). In any case, the observation that
ghrelin action in the AP plays a minor role under more
physiological conditions but becomes relevant during pro-
longed fasting is not unexpected. Indeed, previous studies
have shown that mice need to be exposed to extreme
energy deficit conditions to reveal some essential roles of
ghrelin (34, 35). Thus, we would predict that our current
results may help us to better understand the protective
mechanisms recruited by the ghrelin system in response to
severe energy conditions, including fasting, cachexia, an-
orexia, or malnutrition.
In this study, we show that most GHSR-expressing
cells (;70%) are GABAergic whereas only a relatively
small subset of GABA neurons (;20%) expresses GHSR.
Around 10% of the GABA neurons of
the AP increase c-Fos expression in
response to ghrelin; because no c-Fos is
detected in AP cells lacking GHSR of
ghrelin-treated GHSR-eGFP mice, it
can be inferred that ghrelin activates
approximately half of all GABA neu-
rons expressing GHSR. Because most
GHSR-expressing neurons are acti-
vated by 48-hour fasting, it is possible
to hypothesize that most ghrelin-
responsive GABA neurons of the AP
are recruited under such conditions.
Interestingly, a previous study showed
that ghrelin hyperpolarizes around half
of the ghrelin responding AP neurons,
whereas the other half of them were
depolarized (13). The physiological
implications of this differential role
of ghrelin on different populations of
AP GABA neurons are currently un-
known. In this study, we also showed that TH-IR cells of
the AP do not express GHSR or increase c-Fos levels in
response to ghrelin, indicating that the catecholaminergic
system of the AP is not a target of the hormone in mice.
This finding is similar to previous observations made in
rats (2).
Several studies have shown that ghrelin increases
gastric emptying. In mice, a ghrelin receptor antagonist
reduces gastric emptying (36) whereas ghrelin stimulates
gastric emptying without effects on acid secretion or
gastric endocrine cells (30, 37). Also, GHSR-deficient
mice display a delayed gastric emptying (38), and fasted
mice show increased gastric emptying (39). Gastric emp-
tying is controlled by the vago-vagal reflex pathway,
which involves three sets of neurons: the vagal afferent
neurons of the nodose ganglia that transmit the sensory
information from the gastrointestinal tract to the NTS, the
visceral sensory neurons of the NTS, and the cholinergic
motor neurons of the DMV. The sensory neurons of the
AP can modulate the activity of the vago-vagal reflex (10).
In this study, we found that gastric emptying induced by
peripherally injected ghrelin requires an intact AP. Simi-
larly, the ghrelin-induced pancreatic protein secretion,
which also depends on the vago-vagal reflex, is impaired in
AP-ablated animals (8). It is well established that AP
neurons provide to the NTS an important GABA input,
which regulates the vago-vagal circuit (10, 40, 41). We
found that GHSR-expressing neurons of the AP are
GABAergic and send ventrolateral projections toward the
NTS. Thus, it can be hypothesized that ghrelin-sensitive
GABA neurons of the AP regulate gastric emptying
via modulation of the NTS neurons that are part of the
Figure 5. Ghrelin-induced gastric emptying is impaired in AP-ablated mice. (a) Representative
images of thionin staining of the DVC of AP-intact and AP-ablated animals. Scale bars,
100 mm. (b and c) Bar graphs representing the 2-hour food intake and the percentage of
gastric emptying, respectively, in AP-intact or AP-ablated mice treated with either vehicle or
ghrelin. Data represent the mean 6 SEM. aP , 0.05 vs vehicle groups.
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vago-vagal reflex. In support of this model, a previous
study showed that peripherally administered ghrelin fails
to increase c-Fos in the NTS of AP ablated animals (8).
Still, the ghrelin-induced activation of AP GABA neurons
would induce inhibition of downstream target neurons.
Thus, further studies are required to understand the
neuronal circuits by which ghrelin activates GHSR-
lacking cells of the NTS.
Circulating ghrelin requires the integrity of the AP to
increase gastric emptying; however, we cannot rule out
that such effect involves the simultaneous action on
multiple targets. GHSR is expressed in the nodose ganglia
neurons innervating in the stomach, and ghrelin has been
shown to inhibit vagal afferent responses to tension (42,
43). Thus, ghrelin could increase gastric emptying via
inhibition of the vagal afferents and further reduction of
the inhibitory inputs on the gastric motor function (42). In
rats, ghrelin could also regulate gastrointestinal motility
independently of the vago-vagal reflex, as peripherally
administered ghrelin increases antral contractions in
vagotomized animals (44) and cholinergic antagonists
only partially reduce the effect of ghrelin on gastric
myoelectrical activity and gastric emptying (45). Ex vivo
studies showed that ghrelin stimulates small intestine
motility of rats through intrinsic myenteric neurons, which
also express GHSR (43, 46–48). In mice, ghrelin increases
electrically stimulated contractions of fundic strips in an in
vitro setting (49). It is interesting to stress that the admin-
istration of ghrelin directly in the DVC also elicits con-
tractions of the gastric corpus through the cholinergicDMV
efferent pathway (14). Electrophysiological recordings of
brain slices have shown that ghrelin stimulates the excit-
atory, but not the inhibitory, inputs provided by theNTS to
the preganglionic DMV motor neurons (14) and that it
inhibits the excitatory inputs into the catecholaminergic
neurons of the NTS (50). Because our data indicate that
circulating ghrelin does not have access to the NTS, the
physiological relevance of the direct action of ghrelin on this
DVC region is unclear. We found that GHSR-expressing
neurons of the NTS are responsive to centrally injected
ghrelin; thus, fluctuations of cerebrospinal ghrelin may
regulate GHSR signaling in the NTS. Additionally, GHSR-
expressing cells of the NTS may be regulated by mecha-
nisms independent of ghrelin, as GHSR is known to act in
ligand-independent manner by either its high constitutive
activity or its heterodimerization with other G protein–
coupled receptors (51, 52).
Because the AP also regulates other branches of the
autonomic nervous system, ghrelin may also recruit the
AP to regulate other physiological functions, besides
gastric emptying or pancreatic secretion. For instance,
AP neurons may mediate some effects of ghrelin on
the control of glycemia because mice with selective
expression of GHSR in Phox2b-expressing neurons,
which includes but is not limited to AP neurons,
display a normalization of the relative hypoglycemia
detected in GHSR-deficient mice upon fasting (53).
Additionally, the AP is involved in the control of body
fluid balance, and peripherally administered ghrelin not
only activates the AP but also inhibits water intake in
dehydrated rats (12). Thus, GHSR-expressing neurons
of the APmaymediate some of the antidipsogenic effects
of ghrelin (12). In this regard, it is interesting to stress
that ghrelin-signaling in the AP may be also involved in
the fasting-induced decrease of water consumption.
However, further studies are required to test this
hypothesis.
It is controversial whether the DVC can mediate
orexigenic actions of ghrelin. Early studies showed that
vagotomy or capsaicin treatment, which spares myelin-
ated afferents and lesions nonvagal afferents, abolished
ghrelin-induced food intake (54, 55). However, further
studies using complete subdiaphragmatic deafferentation
indicated that ghrelin does not require vagal afferent
signaling for food intake regulation (56). Ablation of
catecholamine neurons of the medulla also failed to affect
ghrelin-induced food intake (57). In this study, we found
that AP-ablated mice remain fully responsive to the
orexigenic effect of peripherally administered ghrelin.
This observation is in line with our previous studies in-
dicating that the orexigenic effects of peripherally ad-
ministered ghrelin require an intact arcuate nucleus (6), in
which ghrelin targets the AgRP neurons (35, 58), whereas
this effect is not observed in mice with expression of
GHSR limited to Phox2b-expressing cells (53). Inter-
estingly, it has been reported that AP-ablated rats dis-
play a reduced cumulative food intake, after the sixth day
of treatment, in response to daily administrations of
ghrelin (59). The conserved ghrelin-induced food intake
of AP-ablated rats in the initial days of treatment together
with our observation that AP-ablated mice show an
impaired ghrelin-induced gastric emptying suggest that
the role of the AP mediating the effect of ghrelin on
cumulative food intake may be secondary to the effect of
the hormone on the gastrointestinal motility, which could
impact the meal size. Finally, importantly, note that we
cannot exclude the possibility that GHSR-expressing
neurons of the NTS regulate food intake, as it has
been shown that intra-DVC administration of ghrelin
increases food intake (60).
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